XML 16 R4.htm IDEA: XBRL DOCUMENT v3.23.3
Condensed Consolidated Statements of Operations and Comprehensive Income (Loss) - USD ($)
$ in Thousands
3 Months Ended 9 Months Ended
Sep. 30, 2023
Sep. 30, 2022
Sep. 30, 2023
Sep. 30, 2022
Income Statement [Abstract]        
Revenues $ 702 $ 82 $ 929 $ 212
Cost of revenues 280 123 567 316
Gross profit (loss) 422 (41) 362 (104)
Operating expenses:        
Research and development 4,912 7,554 15,629 21,216
Selling, general and administrative 13,936 16,911 37,595 47,250
Total operating expenses 18,848 24,465 53,224 68,466
Operating loss (18,426) (24,506) (52,862) (68,570)
Other income (expense):        
Other income 1,004 346 3,173 395
Interest expense (582) (496) (1,839) (866)
Change in estimated fair value of earn-out liabilities 2,128 77,892 3,182 77,892
Total other income 2,550 77,742 4,516 77,421
Income (loss) before income taxes (15,876) 53,236 (48,346) 8,851
Net income (loss) (15,876) 53,236 (48,346) 8,851
Unrealized gain on short-term investments 25 14 21 7
Comprehensive income (loss) (15,851) 53,250 (48,325) 8,858
Net income (loss) (15,876) 53,236 (48,346) 8,851
Dividends on Series D convertible preferred stock   (1,598)   (7,383)
Redemption value of Series D convertible preferred stock   (799)   (3,692)
Net income (loss) attributable to common stockholders - basic $ (15,876) $ 50,839 $ (48,346) $ (2,224)
Net income (loss) per share attributable to common stockholders - basic $ (0.2) $ 1.38 $ (0.62) $ (0.16)
Net income (loss) per share attributable to common stockholders - diluted $ (0.2) $ 0.76 $ (0.62) $ (0.16)
Weighted average common stock outstanding - basic 78,217,870 36,920,116 78,149,517 13,690,186
Weighted average common shares outstanding - diluted 78,217,870 69,830,970 78,149,517 13,690,186